Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionImpact Partnership Wealth, LLC
Latest Disclosed Ownership13,693 shares
Latest Disclosed Value $ 1,908,381
Impact Partnership Wealth, LLC reports 10.16% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 23, 2026 - Impact Partnership Wealth, LLC filed a 13F-HR form disclosing ownership of 13,693 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,908,381 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 15,241 shares of Gilead Sciences, Inc.. This represents a change in shares of -10.16% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F GILEAD SCIENCES COM 375558103 13,693 -1,548 -10.16 1,908 2.03 0.2356
2026-02-10 2025-12-31 13F GILEAD SCIENCES COM 375558103 15,241 -910 -5.63 1,871 4.35 0.2399
2025-11-03 2025-09-30 13F GILEAD SCIENCES COM 375558103 16,151 3,013 22.93 1,793 23.08 0.2666
2025-08-04 2025-06-30 13F GILEAD SCIENCES COM 375558103 13,138 5,232 66.18 1,457 64.52 0.2686
2025-05-05 2025-03-31 13F GILEAD SCIENCES COM 375558103 7,906 -5,044 -38.95 886 -26.00 0.1892
2025-01-21 2024-12-31 13F GILEAD SCIENCES COM 375558103 12,950 194 1.52 1,196 11.88 0.2414
2024-10-22 2024-09-30 13F GILEAD SCIENCES COM 375558103 12,756 -198 -1.53 1,069 20.38 0.2413
2024-08-02 2024-06-30 13F GILEAD SCIENCES COM 375558103 12,954 -1,008 -7.22 889 -13.11 0.2335
2024-05-13 2024-03-31 13F GILEAD SCIENCES COM 375558103 13,962 4,375 45.63 1,023 31.70 0.4053
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 9,587 2,742 40.06 777 51.56 0.2838
2023-10-17 2023-09-30 13F GILEAD SCIENCES COM 375558103 6,845 2,708 65.46 513 61.01 0.1596
2023-07-17 2023-06-30 13F GILEAD SCIENCES COM 375558103 4,137 4,137 319 0.1108
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.